LETTER
Microwave-Assisted Stille Reactions
59
(18) General Procedure: A mixture of 3,5-dibromo-1-methyl-
1H-1,2,4-triazole (1; 200 mg, 0.83 mmol), stannyl derivative
(2; 1.08 mmol), PdCl2(PPh3)2 (12 mg, 0.017 mmol) and LiCl
(106 mg, 2.49 mmol) or CuI (15.8 mg, 0.083 mmol) was
irradiated under argon in a Discover™ (CEM) focused
microwave reactor at 110 °C for 15 min. The crude products
3a and 4a–g were purified by flash chromatography on silica
gel (hexane–EtOAc).
(CDCl3): d = 157.3, 150.0, 133.5, 128.9, 128.7, 128.6, 127.9,
127.6, 126.3, 126.2, 37.1 (CH3).
1-Methyl-3,5-bis(1-methyl-1H-pyrrol-2-yl)-1H-1,2,4-
triazole (5b): Mp 78–79 °C; 1H NMR (CDCl3): d = 6.74 (t,
J = 2.0 Hz, 1 H, H-5¢¢), 6.73 (dd, J = 2.0, 1.0 Hz, 1 H, H-5¢),
6.62 (t, J = 2.0 Hz, 1 H, H-3¢), 6.43 (dd, J = 4.4, 2.4 Hz, 1 H,
H-3¢¢), 6.17 (dd, J = 4.0, 2.4 Hz, 1 H, H-4¢¢), 6.10 (dd,
J = 3.4, 2.9 Hz, 1 H, H-4¢), 3.94 (s, 3 H, CH3), 3.91 (s, 3 H,
CH3), 3.85 (s, 3 H, CH3); 13C NMR (CDCl3): d = 155.9,
148.0, 126.1, 125.0, 124.8, 119.8, 112.3, 110.3, 108.0,
107.7, 36.7 (CH3), 36.6 (CH3), 36.1 (CH3).
3,5-Di(2,2¢-bithiophen-5-yl)-1-methyl-1H-1,2,4-triazole
(5c): Mp 146–148 °C; 1H NMR (CDCl3): d = 7.61 (d, J = 3.8
Hz, 1 H, H-3¢¢), 7.45 (d, J = 3.8 Hz, 1 H, H-3), 7.22–7.31 (m,
5 H, H-4, H-3¢, H-5¢, H-3¢¢¢, H-5¢¢¢), 7.17 (d, J = 3.8 Hz, 1 H,
H-4¢¢), 7.07 (dd, J = 4.9, 3.8 Hz, 1 H), 7.03 (t, J = 4.3 Hz,
1 H, H-4¢ and H-4¢¢¢); 13C NMR (CDCl3): d = 156.9, 149.7,
140.8, 138.2, 137.2, 136.1, 131.9, 129.0, 128.1, 127.9,
127.2, 126.9, 125.6, 124.8, 124.7, 124.2, 124.1, 124.0, 37.3
(CH3).
5-Bromo-1-methyl-3-(thiophen-2-yl)-1H-1,2,4-triazole
(3a): Mp 54–55 °C; 1H NMR (CDCl3): d = 7.58 (dd, J = 3.7,
1.2 Hz, 1 H, H-3¢), 7.28 (dd, J = 5.1, 1.2 Hz, 1 H, H-5¢), 7.02
(dd, J = 5.1, 3.7 Hz, 1 H, H-4¢), 3.84 (s, 3 H, CH3); 13C NMR
(CDCl3): d = 159.0, 132.8, 129.7, 127.7, 126.8, 126.5, 36.5
(CH3).
3-Bromo-1-methyl-5-(thiophen-2-yl)-1H-1,2,4-triazole
(4a): Mp 67–68 °C; 1H NMR (CDCl3): d = 7.54–7.62 (m,
2 H, H-3¢¢, H-5¢¢), 7.19 (dd, J = 5.1, 3.7 Hz, 1 H, H-4¢¢), 4.06
(s, 3 H, CH3); 13C NMR (CDCl3): d = 151.1, 138.7, 129.4,
129.0, 128.0, 127.9, 37.4 (CH3).
3-Bromo-1-methyl-5-(1-methyl-1H-pyrrol-2-yl)-1H-
1,2,4-triazole (4b): Mp 41–42 °C; 1H NMR (CDCl3): d =
6.74 (t, J = 1.8 Hz, 1 H, H-5¢¢), 6.41 (dd, J = 4.0, 1.5 Hz, 1 H,
H-3¢¢), 6.14 (dd, J = 3.7, 2.6 Hz, 1 H, H-4¢¢), 4.06 (s, 3 H,
CH3); 13C NMR (CDCl3): d = 149.9, 138.3, 126.8, 118.3,
113.1, 108.2, 37.1 (CH3), 36.0 (CH3).
5-(2,2¢-Bithiophen-5-yl)-3-bromo-1-methyl-1H-1,2,4-
triazole (4c): Mp 152–154 °C; 1H NMR (CDCl3): d = 7.61
(d, J = 3.9 Hz, 1 H, H-3), 7.31 (dd, J = 5.1, 1.1 Hz, 1 H, H-
3¢), 7.27 (dd, J = 3.8, 1.1 Hz, 1 H, H-5¢), 7.20 (d, J = 3.9 Hz,
1 H, H-4), 7.05 (dd, J = 5.1, 3.8 Hz, 1 H, H-4¢); 13C NMR
(CDCl3): d = 150.7, 141.7, 138.7, 135.7, 129.5, 128.1, 125.9,
125.9, 125.0, 124.1, 35.5 (CH3).
(20) General Procedure: A mixture of 5-monosubstituted
triazole 4 (1 equiv), stannyl derivative (2; 1.3 equiv),
PdCl2 (PPh3)2 (0.02 equiv) and LiCl (3 equiv) or CuI (0.1
equiv) was irradiated at the appropriate temperature and for
the appropriate time under argon in a Discover™ (CEM)
focused microwave reactor. The crude products 6a–c were
purified by flash chromatography on silica gel (hexane–
EtOAc).
1-Methyl-3-(1-methyl-1H-pyrrol-2-yl)-5-(thiophen-2-
yl)-1H-1,2,4-triazole (6a): Mp 88–89 °C; 1H NMR
(CDCl3): d = 7.53 (dd, J = 3.7, 1.5 Hz, 1 H, H-3¢¢), 7.52 (dd,
J = 5.1, 1.1 Hz, 1 H, H-5¢¢), 7.18 (dd, J = 5.1, 3.7 Hz, 1 H, H-
4¢¢), 6.81 (dd, J = 3.7, 1.8 Hz, 1 H, H-5¢), 6.70 (t, J = 2.2 Hz,
1 H, H-3¢), 6.17 (dd, J = 3.7, 2.6 Hz, 1 H, H-4¢), 4.08 (s, 3 H,
CH3), 4.00 (s, 3 H, CH3); 13C NMR (CDCl3): d = 156.3,
149.1, 129.5, 128.5, 128.2, 127.8, 125.2, 124.4, 110.8,
107.8, 37.0 (CH3), 36.5 (CH3).
3-Bromo-1-methyl-5-phenyl-1H-1,2,4-triazole (4d): Mp
120–121 °C; 1H NMR (CDCl3): d = 7.59–7.61 (m, 2 H, o-
PhH), 7.44–7.46 (m, 3 H, m-PhH, p-PhH), 3.91 (s, 3 H,
CH3); 13C NMR (CDCl3): d = 156.6, 139.1, 130.7, 129.0,
128.7, 126.7, 37.3 (CH3).
3-Bromo-1-methyl-5-(phenylethynyl)-1H-1,2,4-triazole
(4e): Mp 119–120 °C; 1H NMR (CDCl3): d = 7.52–7.55 (m,
2 H, o-PhH), 7.28–7.94 (m, 3 H, m-PhH, p-PhH), 3.97 (s,
3 H, CH3); 13C NMR (CDCl3): d = 147.7, 140.3, 132.1,
132.0, 129.2, 128.7, 128.4, 121.7, 97.4, 89.5, 36.5 (CH3).
2-(3-Bromo-1-methyl-1H-1,2,4-triazol-5-yl)pyridine(4f):
Mp 78–80 °C; 1H NMR (CDCl3): d = 8.68 (dd, J = 4.8, 1.8
Hz, 1 H, H-6), 8.20 (dd, J = 7.7, 1.1 Hz, 1 H, H-3), 7.85 (td,
J = 7.7, 1.8 Hz, 1 H, H-4), 7.37 (ddd, J = 7.7, 4.8, 1.1 Hz,
1 H, H-5), 4.36 (s, 3 H, CH3); 13C NMR (CDCl3): d = 153.4,
148.9, 146.8, 138.3, 137.1, 124.5, 124.0, 39.3 (CH3).
2-(3-Bromo-1-methyl-1H-1,2,4-triazol-5-yl)pyrazine
(4g): Mp 131–133 °C; 1H NMR (CDCl3): d = 9.45 (s, 1 H,
H-3), 8.67, 8.64 (2 × s, 2 H, H-5 and H-6), 4.34 (s, 3 H,
CH3); 13C NMR (CDCl3): d = 151.1, 145.2, 154.1, 143.1,
142.5, 138.8, 39.3 (CH3).
3-(2,2¢-Bithiophen-5-yl)-1-methyl-5-(thiophen-2-yl)-1H-
1,2,4-triazole (6b): Mp 124–126 °C; 1H NMR (CDCl3): d =
7.62 (d, J = 3.8 Hz, 1 H, H-4¢¢), 7.57 (dd, J = 3.7, 1.1 Hz,
1 H, H-3¢¢¢), 7.55 (dd, J = 5.1, 1.1 Hz, 1 H, H-5¢¢¢), 7.24–7.23
(m, 2 H, H-3¢, H-5¢), 7.20 (dd, J = 5.1, 3.7 Hz, 1 H, H-4¢¢¢),
7.07 (dd, J = 3.8 Hz, 1 H, H-3¢¢), 7.03 (dd, J = 3.8, 4.9 Hz,
1 H, H-4¢), 4.09 (s, 3 H, CH3); 13C NMR (CDCl3): d = 156.9,
150.1, 138.2, 137.2, 131.9, 128.9, 128.8, 128.7, 127.9,
126.9, 124.7, 124.4, 124.0, 37.2 (CH3).
2-[1-Methyl-3-(thiophen-2-yl)-1H-1,2,4-triazol-5-
yl]pyrazine (6c): Mp 139–140 °C; 1H NMR (CDCl3): d =
9.55 (d, J = 1.7 Hz, 1 H, H-3 Py), 8.64–8.67 (m, 2 H, H-5,
H-6 Py), 7.75 (dd, J = 3.7, 1.1 Hz, H-3 thioph), 7.37 (dd,
J = 5.1, 1.1 Hz, 1 H, H-5 thioph), 7.13 (dd, J = 5.1, 3.7 Hz,
1 H, H-4 thioph), 4.37 (s, 3 H, CH3); 13C NMR (CDCl3): d =
157.5, 150.1, 145.4, 144.7, 143.5, 143.0, 133.5, 127.7,
126.5, 126.3.
(19) General Procedure: A mixture of 3,5-dibromo-1-methyl-
1H-1,2,4-triazole (1; 200 mg, 0.83 mmol), stannyl derivative
(2; 2.16 mmol, 2.6 equiv), PdCl2 (PPh3)2 (24 mg, 0.033
mmol) and LiCl (106 mg, 2.49 mmol) was irradiated under
argon in a Discover™ (CEM) focused microwave reactor at
130 °C for the appropriate time. The crude products 5a–c
were purified by flash chromatography on silica gel
(hexane–EtOAc).
(21) General Procedure: A mixture of 1-phenyl-4-(tributyl-
stannyl)-1H-1,2,3-triazole (11; 100 mg, 0.23 mmol),
halogenated derivative 12 (0.25 mmol), PdCl2(PPh3)2 (3 mg,
0.004 mmol) and LiCl (29.3 mg, 0.69 mmol) was irradiated
at the appropriate temperature and for the appropriate time
under argon in a Discover™ (CEM) focused microwave
reactor. The crude products 13a–g were purified by flash
chromatography (hexane–EtOAc).
1-Methyl-3,5-di(thiophen-2-yl)-1H-1,2,4-triazole (5a):
Mp 107–108 °C; 1H NMR (CDCl3): d = 7.71 (dd, J = 3.7, 1.1
Hz, 1 H, H-3¢), 7,54 (dd, J = 3.7, 1.1 Hz, 1 H, H-3¢¢), 7.53
(dd, J = 5.1, 1.1 Hz, 1 H, H-5¢¢), 7.34 (dd, J = 4.8, 1.1 Hz,
1 H, H-5¢), 7.18 (dd, J = 5.1, 3.7 Hz, 1 H, H-4¢¢), 7.10 (dd,
J = 5.1, 3.7 Hz, 1 H, H-4¢), 4.07 (s, 3 H, CH3); 13C NMR
4-(3,5-Dimethylphenyl)-1-phenyl-1H-1,2,3-triazole
(13a): Mp 115–116 °C; 1H NMR (CDCl3): d = 8.1 (s, 1 H,
H-5), 7.8 (d, J = 7.3 Hz, 2 H, o-PhH), 7.5 (m, 4 H, Ph¢H), 7.4
(t, J = 7.3 Hz, 1 H, p-Ph¢H), 7.0 (s, 1 H, p-PhH), 2.2 (s, 6 H,
2 × CH3); 13C NMR (CDCl3): d = 148.6, 138.5, 137.1, 130.1,
Synlett 2010, No. 1, 55–60 © Thieme Stuttgart · New York